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Spectra VRE (Remel, Lenexa, KS) is a chromogenic medium designed to recover and differentiate vanco-
mycin-resistant Enterococcus faecium and Enterococcus faecalis (VRE). This medium was compared to bile
esculin azide agar (BEAV) and was 98.2% sensitive and 99.3% specific compared to BEAV, which was 87.6%
sensitive and 87.1% specific at 24 h.
Two Enterococcus species, E. faecalis and E. faecium,
cause the majority of human enterococcal infections (1).
The rapid strain identification for patients colonized in the
gastrointestinal tract with vancomycin-resistant strains of
these species (VRE) is critical, as infection with these or-
ganisms can result in endocarditis, urinary tract, blood-
stream, and wound infections with reduced therapeutic op-
tions (3). Screening for VRE is essential for the proper
implementation of isolation precautions, as asymptomatic
carriers serve as reservoirs for VRE infection or transmis-
sion (4, 7, 9). Successful identification of patients colonized
with VRE requires rapid and accurate screening tests that
are easily interpretable. The purpose of this multicenter
study was to compare the performance of a new chromo-
genic medium, Spectra VRE, to bile esculin azide agar sup-
plemented with 6 g vancomycin/ml (BEAV; Remel) as a
means of screening stool specimens for VRE colonization.
Stool specimens were collected from inpatients in sterile
containers for Clostridium difficile testing and stored at 4°C
for up to 3 days. Specimens were plated with a sterile Da-
cron swab to BEAV and Spectra VRE and streaked for
isolation by the quadrant technique. Inoculated plates were
incubated at 35°C in ambient air and examined for growth at
18, 24, and 48 h. Pink, purple, or dark blue colonies on
Spectra VRE were presumptively identified as vancomycin-
resistant E. faecium. Light blue colonies on Spectra VRE
were presumptively identified as vancomycin-resistant E.
faecalis. Presumed VRE colonies on BEAV appeared dark
brown or black.
Presumptive VRE from Spectra VRE and BEAV were
subcultured to tryptic soy agar plates (TSA; Remel) and
incubated at 35°C for 24 h. Catalase-negative, Gram-posi-
tive cocci positive for L-pyrrolidonyl--naphthylamide
(PYR; Remel) were further identified using methyl--D-
glucopyranoside (MDG; Remel), motility test medium (Re-
mel), PB arabinose (Remel), and colony morphology on
blood agar. VRE isolates were identified based on the fol-
lowing performance characteristics: E. faecalis, MDG-neg-
* Corresponding author. Mailing address: Department of Pathology,
Medical College of Wisconsin, 9200 West Wisconsin Ave., Milwaukee,
WI 53226. Phone: (414) 805-7556. E-mail: nledeboe@mcw.edu.
 Published ahead of print on 13 October 2010.
TABLE 1. Analysis of Spectra VRE and BEAV for the detection of VRE from 399 fecal specimens at 18, 24, and 48 h (combined data)
Incubation period (h) Medium
No. ofa:
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
TP FP TN FN
18 Spectra VRE 103 1 285 10 91.2 99.7 99.0 96.6
BEAV 83 28 258 30 73.5 90.2 74.8 89.6
24 Spectra VRE 111 2 284 2 98.2 99.3 98.2 99.3
BEAV 99 37 249 14 87.6 87.1 72.8 94.7
48 Spectra VRE 112 10 276 1 99.1 96.5 91.8 99.6
BEAV 106 79 207 7 93.8 72.4 57.3 96.7
a True-positive results (TP) are defined as pink-, purple-, or blue-pigmented colonies on Spectra VRE or brown-black colonies on BEAV that were identified as VRE
with supplemental testing and confirmed with the vancomycin Etest (32 g/ml). FP, false-positive results; TN, true-negative results; FN, false-negative results.
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ative, nonmotile, arabinose-negative, white colonies; E. fae-
cium, MDG-negative, nonmotile, arabinose-positive, gray
colonies. The Etest (bioMe´rieux, Durham, NC) was per-
formed to determine the vancomycin MIC of each isolate.
Breakpoints for VRE were interpreted as defined by CLSI
guidelines (2). Confirmatory identification and antimicro-
bial susceptibility testing were also performed with the
Vitek 2 (bioMe´rieux). All confirmed VRE isolates from
Spectra VRE agar were identified by 16S rRNA gene se-
quencing using the MicroSeq 500 protocol (Applied Biosys-
tems, Carlsbad, CA). Generated sequences were analyzed
using the Basic Local Assignment Search Tool (BLAST), a
search engine provided by the National Center for Biotech-
nology Information (NCBI).
Appropriately colored colonies growing on either me-
dium, confirmed as VRE by sequencing and vancomycin
MIC  32 mg/ml, served as the gold standard for this study.
The combined sensitivity and specificity of Spectra VRE
were 91.2% and 99.7% following 18 h of incubation, 98.2%
and 99.3% at 24 h, and 99.1% and 96.5% at 48 h, respec-
tively (Table 1). Two of the three false positives reported at
site A were attributed to the growth of single light blue
colonies that were both identified as vancomycin-sensitive
E. faecalis. The remaining false-positive isolate produced
multiple pink colonies and was identified as a Lactobacillus
sp. Four of the seven false positives reported at site B
produced pink colonies that were identified as Gram-posi-
tive bacilli. Two of the seven false positives produced blue
colonies that were identified as Pediococcus spp. The re-
maining false-positive isolate, which produced blue-green
colonies, was identified as Enterococcus durans. In addition,
one false-negative result was reported from site B in which
vancomycin-resistant E. faecium was recovered on BEAV at
24 h and demonstrated no growth on Spectra VRE after
48 h of incubation.
By comparison, the combined sensitivity and specificity of
BEAV for the detection of VRE at 18, 24, and 48 h were
73.5% and 90.2%, 87.6% and 87.1%, and 93.8% and 72.4%,
respectively (Table 1). The reduced specificity of BEAV
agar stemmed from the growth of Lactobacillus spp., Lac-
tococcus spp., Pediococcus spp., and Enterococcus spp. other
than E. faecalis or E. faecium at both trial sites (Fig. 1). The
combined positive predictive value (PPV) and negative pre-
dictive value (NPV) of both media are shown in Table 1.
Colonies recovered from site A on Spectra VRE were
differentiated based on pink, purple, dark, or light blue
pigmentation. A total of 51 vancomycin-resistant E. faecium
isolates were recovered on Spectra VRE. The sensitivity of
Spectra VRE based on colony pigmentation alone at 18, 24,
and 48 h was 94.1%, 98.0%, and 100.0%, respectively. For
site B, the process for colony selection and identification
was similar, but this group did not differentiate between
dark and light blue colonies. A total of 61 vancomycin-
resistant E. faecium isolates and 1 vancomycin-resistant E.
faecalis isolate were recovered on Spectra VRE at site B.
FIG. 1. Growth of contaminants on each medium at 18, 24, and
48 h. Contaminants are classified as potential false-positive isolates.
Colonies demonstrating any hue of pink, purple, or blue were clas-
sified as potentially false positive on Spectra VRE; isolates with a
brown-black hue were classified as potentially false positive on
BEAV.
TABLE 2. Analysis of Spectra VRE and BEAV for the detection of VRE from fecal specimens at 18, 24,
and 48 h (individual clinical trial site results)
Clinical site and
incubation
period (h)
Medium
No. ofa:
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
TP FP TN FN
Clinical site A
18 Spectra VRE 48 1 114 3 94.1 99.1 98.0 97.4
BEAV 30 11 104 21 58.8 90.4 73.2 83.2
24 Spectra VRE 50 2 113 1 98.0 98.3 96.2 99.1
BEAV 40 14 101 11 78.4 87.8 74.1 90.2
48 Spectra VRE 51 3 112 0 100.0 97.4 94.4 100.0
BEAV 45 31 84 6 88.2 73.0 59.2 93.3
Clinical site B
18 Spectra VRE 55 0 171 7 88.7 100.0 100.0 96.1
BEAV 53 17 154 9 85.5 90.1 75.7 94.5
24 Spectra VRE 61 0 171 1 98.4 100.0 100.0 99.4
BEAV 59 23 148 3 95.2 86.5 72.0 98.0
48 Spectra VRE 61 7 164 1 98.4 95.9 89.7 99.4
BEAV 61 48 123 1 98.4 71.9 56.0 99.2
a True-positive results (TP) are defined as pink-, purple-, or blue-pigmented colonies on Spectra VRE or brown-black colonies on BEAV that were identified as VRE
with supplemental testing and confirmed with the vancomycin Etest (32 g/ml). FP, false-positive results; TN, true-negative results; FN, false-negative results.
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The sensitivity of Spectra VRE at site B (based on colony
pigmentation) was 88.7% at 18 h and 98.4% at 24 and 48 h.
Independent clinical trial site analyses of Spectra VRE and
BEAV are shown in Table 2. Differences in sensitivity of
BEAV at 18 and 24 h at sites A and B may have been due
to reading technique or different circulating clones of VRE;
regardless, data from both sites highlight the lack of sensi-
tivity and specificity when using BEAV to screen for VRE.
VRE isolates recovered on Spectra VRE were sequenced
for identification. Two discrepancies were observed between
the Vitek 2, biochemical testing, and sequence analyses.
Several pink colonies recovered at 24 h of incubation were
identified as E. faecium by the Vitek 2 and biochemical
testing but were most closely related to E. faecalis by se-
quence analysis (99% identification). Similarly, several light
blue colonies observed at 18 h of incubation were identified
by the Vitek 2 and biochemical testing as E. faecalis but by
sequencing as E. faecium (98% identification).
The rapid detection of VRE colonization is critical for proper
infection control. Traditional culture methods that rely on colony
morphology, biochemical characteristics, and susceptibility
testing may take up to 5 days, thus prolonging effective patient
management (8). Several chromogenic media have been de-
veloped to date, including chromID VRE (bioMe´rieux) (6)
and CHROMagar VRE (BD, Baltimore, MD) (5), that detect
VRE rapidly with high sensitivity and specificity. The data
presented in this report demonstrate that Spectra VRE can
also rapidly identify VRE with high sensitivity and specificity
following 24 h of incubation, regardless of the ability to differ-
entiate to species, when distinguishing VRE from common
stool flora based on pink-, purple-, or blue-pigmented colonies.
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